Latest Asx Announcements News

CONNEQT Health has landed a significant Phase 2b clinical trial contract in the US, advancing its footprint in cardiovascular disease research with proprietary vascular assessment technology.

Arovella Therapeutics has secured encouraging feedback from the US FDA on reagent testing for its CAR-iNKT cell therapy, setting the stage for an IND filing this quarter and clinical trials in early 2026.

Alcidion Group Limited has reported a robust start to FY26, posting $8.2 million in new sales and significantly improving its operating cash flow. The company reaffirms its guidance for positive EBITDA and cash flow for the full year.

Clarity Pharmaceuticals has responded to ASX queries clarifying the timing and materiality of its SAR-bisFAP data presentation, denying the information was price sensitive despite a notable share price rise.

Coda Minerals has raised $12.33 million to fully fund the Pre-Feasibility Study for its Elizabeth Creek Copper-Silver Project, with drilling now underway and a robust work program planned through 2026.

EMU NL has appointed John Anderson as Chair and Adrian Griffin as Managing Director and CEO, marking a significant step in its board renewal process aligned with ASX governance standards.

Premier1 Lithium Limited’s PLCO securities have been suspended from trading due to regulatory non-compliance, raising questions about the company’s next steps and market impact.

Aguia Resources Limited’s AGRO securities have been suspended from trading by ASX Compliance, pending regulatory compliance. The move raises questions about the company’s current standing and next steps.

ASF Group Limited has voluntarily suspended trading of its securities on the ASX pending a response to regulatory queries, signaling heightened scrutiny and market uncertainty.

Axiom Properties Limited and Securexchange have teamed up to launch Settlement Advance, a financial solution allowing property sellers to access up to $350,000 of their home equity before settlement, streamlining the property transaction process.

Clara Resources Australia Limited has announced a fully underwritten entitlement offer to raise approximately $1.27 million, aimed at funding drilling and development activities at its Ashford Coking Coal project. The offer follows a recent placement and includes a shortfall facility for eligible shareholders.

Vectus Biosystems has had its ASX trading suspension lifted following the disclosure of a significant transaction involving a compound from its drug library, signaling renewed investor interest.